Manome Y - Search Results

1

Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo.

Hayashi N, Asano K, Suzuki H, Yamamoto T, Tanigawa N, Egawa S, Manome Y. Hayashi N, et al. Among authors: manome y. Prostate. 2005 Sep 15;65(1):10-9. doi: 10.1002/pros.20232. Prostate. 2005. PMID: 15799033

2

Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.

Yamamoto T, Manome Y, Nakamura M, Tanigawa N. Yamamoto T, et al. Among authors: manome y. Eur J Cancer. 2002 Nov;38(17):2316-24. doi: 10.1016/s0959-8049(02)00247-2. Eur J Cancer. 2002. PMID: 12441269

3

[Development of a novel gene therapy using survivin antisense expressing adenoviral vectors].

Yamamoto T, Manome Y, Miyamoto A, Tanigawa N. Yamamoto T, et al. Among authors: manome y. Gan To Kagaku Ryoho. 2003 Oct;30(11):1805-8. Gan To Kagaku Ryoho. 2003. PMID: 14619525 Japanese.

4

Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.

Manome Y, Watanabe M, Abe T, Tomita M, Watanabe S, Yokokawa Y, Takahashi Y, Ishii K, Kimura A, Murakami M, Nagata M, Shibata T, Nakamura M, Tanigawa N, Ohno T. Manome Y, et al. Anticancer Res. 2001 Jul-Aug;21(4A):2265-72. Anticancer Res. 2001. PMID: 11724281

5

Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.

Kojima H, Iida M, Yaguchi Y, Suzuki R, Hayashi N, Moriyama H, Manome Y. Kojima H, et al. Among authors: manome y. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):682-5. doi: 10.1001/archotol.132.6.682. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16785416

6

Enhancement of cyclophosphamide sensitivity in squamous cell carcinoma transfected with cytochrome P-450 2B1.

Iida M, Kojima H, Miyazaki H, Manome Y. Iida M, et al. Among authors: manome y. Am J Otolaryngol. 2005 Jan-Feb;26(1):22-7. doi: 10.1016/j.amjoto.2004.06.012. Am J Otolaryngol. 2005. PMID: 15635577

7

Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.

Manome Y, Yoshinaga H, Watanabe M, Ohno T. Manome Y, et al. Anticancer Res. 2002 Jul-Aug;22(4):2029-36. Anticancer Res. 2002. PMID: 12174880

8

The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells.

Inaba N, Kimura M, Fujioka K, Ikeda K, Somura H, Akiyoshi K, Inoue Y, Nomura M, Saito Y, Saito H, Manome Y. Inaba N, et al. Among authors: manome y. Anticancer Res. 2011 May;31(5):1653-8. Anticancer Res. 2011. PMID: 21617223

9

Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.

Manome Y, Kunieda T, Wen PY, Koga T, Kufe DW, Ohno T. Manome Y, et al. Hum Gene Ther. 1998 Jul 1;9(10):1409-17. doi: 10.1089/hum.1998.9.10-1409. Hum Gene Ther. 1998. PMID: 9681412

10

MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.

Funamizu N, Lacy CR, Kamada M, Yanaga K, Manome Y. Funamizu N, et al. Among authors: manome y. Int J Oncol. 2015 Nov;47(5):1981-8. doi: 10.3892/ijo.2015.3178. Epub 2015 Sep 22. Int J Oncol. 2015. PMID: 26397233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters